HOME >> MEDICINE >> NEWS
OneWorld Health licenses compounds from Yale, U of Washington to treat major parasitic diseases

San Francisco, Calif. July 8, 2003 -- The Institute for OneWorld Health, the first nonprofit pharmaceutical company in the United States, announced today it has licensed a novel class of high-potency compounds from Yale University and the University of Washington that could result in medicines for the developing and developed worlds.

The agreement gives OneWorld Health the exclusive license to develop the azole compounds to treat parasitic diseases in the developing world. OneWorld Health will initially focus on the use of the azoles in Chagas disease, the leading cause of heart failure in Latin America, where 16 to 18 million people are infected and another 100 million are at risk. The disease is most often transmitted by an insect known as the "kissing bug," but may also be transmitted by blood transfusion. At least 50,000 to 100,000 people in the U.S. are infected as well.

The licensing agreement also creates a dual market opportunity in which the universities could seek a pharmaceutical partner to develop the same compounds for fungal infections in industrialized countries.

OneWorld Health will conduct appropriate pre-clinical tests after selecting a lead candidate among the compounds, which represent the first new potential drugs to treat Chagas disease in decades. The compounds were developed by teams led by Andrew Hamilton, deputy provost for science and technology at Yale and professor of chemistry, in collaboration with Frederick Buckner, Michael Gelb, Wesley Van Voorhis, and Kohei Yokoyama, all professors at the University of Washington in Seattle.

"We are delighted that these potent anti-Chagas agents have been licensed to an organization that is committed to their development for treatment of this terrible parasitic disease," said Hamilton, of Yale. "We look forward to working with OneWorld Health to produce drug leads that will push these compounds into pre-clinical development and beyond."

"There is more optim
'"/>

Contact: Sedef Onder
sonder@thehaloproject.com
917-570-8934
Institute for OneWorld Health
8-Jul-2003


Page: 1 2 3

Related medicine news :

1. OneWorld Health begins final testing of drug to cure deadly kala azar in India
2. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
3. Liverpool to lead 20M Department of Health initiative to develop medicines for children
4. Health care report cards may increase racial/ethnic disparities in bypass operations
5. 2005 Behavioral Sciences & Health Services Research Award
6. Statement on the findings of the Womens Health Study
7. Bone density returns when teens stop using Depo Provera, Group Health study finds
8. Mailman School of Public Health researchers develop infectious disease diagnostic tool
9. Health initiatives can help peace building in the Middle East
10. Study naming hospitals in top 5% for clinical quality released by HealthGrades
11. RelayHealth selected by Columbia University to link doctors and patients online

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... August 05, 2020 , ... CentrAlert, Inc. today ... gain access to essential COVID-19 information. Know NOW!, which is available for Apple ... and unify them in one easy-to-use mobile application. , “When COVID-19 first hit, there ...
(Date:8/5/2020)... ... August 04, 2020 , ... Total ... Autism Spectrum Disorder (ASD) in Wisconsin, is delighted to announce the grand opening ... opening of their newest center, Total Spectrum now proudly serves ten different locations ...
(Date:8/5/2020)... ... August 04, 2020 , ... Today, Power to Decide’s ... Health Programs (AMCHP) with the 2020 Innovation Station Best Practice Award. The One Key ... under what circumstances to get pregnant and have a child. One Key Question is ...
(Date:8/3/2020)... ... 03, 2020 , ... WorkBook6 – a Tempe, Arizona-based partnership ... site provides a simple and efficient way for Americans over the age of ... an important expansion for the insurance marketing ecosystem, and a critical service for ...
(Date:8/3/2020)... ... August 03, 2020 , ... Actuate ... first patients with first-line advanced pancreatic cancer in a phase 2 study of ... 9-ING-41, (NCT03678883, EudraCT#:2018-003739-32). 9-ING-41 is Actuate’s proprietary small molecule glycogen synthase kinase-3 ...
Breaking Medicine News(10 mins):
(Date:7/31/2020)... ... ... In an informal poll of 150 fans, conducted by long-time Twins fan ... “Minnie and Paul” logo that is more racially and culturally sensitive and inclusive. The ... civil rights movement in the United States. The Minnesota Twins have never updated their ...
(Date:7/18/2020)... , ... July 17, 2020 , ... ... COVID-19,” an extensive awareness campaign to let those who are experiencing abuse know ... seek the services they need through the Miami-Dade County’s Coordinated Victim’s Assistance Center ...
(Date:7/10/2020)... ... July 10, 2020 , ... The Dolphin Company, the ... more than 12 million guests, unveiled its new comprehensive plan of protocols and ... in all facets of the operation, safety, and health addressing COVID-19. , Experts ...
Breaking Medicine Technology:
Cached News: